AS PHARMA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
26-08
micro format · 26 days late
2025
29-08
micro format · 29 days late
07-02
Gazette deed
Registered office moved from Nivelles to DampremyNew seat: Rue Jean Jaurès, 272 6020 Dampremy · Previous seat: Rue de Namur 134 - 1400 Nivelles2 points ▸
Gazette deed
Registered office moved from Nivelles to Dampremy
New seat: Rue Jean Jaurès, 272 6020 Dampremy · Previous seat: Rue de Namur 134 - 1400 Nivelles2 points ▸
- General meeting, 31-12-2024
- Registered-office move, Rue Jean Jaurès, 272 6020 Dampremy
2024
31-12
Financial
Highest result from 2023 to 2025net €80,929 ▲2,358%
The operating result of €148,747 and the net result of €80,929 are both a record.
31-12
Financial
Equity above €100,000equity €134,222 ▲152%
With a profit in every financial year since 2023, equity grows to €134,222.
27-09
micro format · 58 days late
31-01
Gazette deed
Capital increase to €50,000Permanent representative: Alessio STEFANELLI4 points ▸
Gazette deed
Capital increase to €50,000
Permanent representative: Alessio STEFANELLI4 points ▸
- General meeting, 28-12-2023
- Permanent representative, Alessio STEFANELLI
- Other provision, 21:30, “clôture de la séance” (deed in French)
- Capital increase, €50,000
2022
12-10
Gazette deed
IncorporationStarting capital €5,000 · Appointment: STEFANELLI Alessio Jean David (director) · Registered office clause · Board rule14 points ▸
Gazette deed
Incorporation
Starting capital €5,000 · Appointment: STEFANELLI Alessio Jean David (director) · Registered office clause · Board rule14 points ▸
- Other provision, “absence de faillite, n'avoir été déclaré en faillite jusqu'à ce jour” (deed in French)
- Other provision, “autorisations et licences préalables, notaire a attiré attention sur fait que société pourrait devoir se procurer autorisations et licences requises par régleme…” (deed in French)
- Other provision, “frais de constitution”, 1809.3 (deed in French)
- Registered office clause, “rue de Namur numéro 134, Nivelles” (deed in French)
- Board rule, 1, “assemblée” (deed in French)
- Director appointment, STEFANELLI Alessio Jean David (director)
- Pre-incorporation commitments, “takeover, engagements,obligations et activités entreprises au nom et pour compte de la société en formation” (deed in French)
- Incorporation, 29-09-2022
- Founder, STEFANELLI Alessio Jean David (comparant)
- Founding capital, €5,000
- Other provision, “plan financier et capitaux propres de départ”, yes (deed in French)
- Other provision, “avertissements du notaire avant constitution” (deed in French)
- The act holds 2 more points.
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
On 10 October 2022, AS PHARMA was incorporated as a private limited company by one natural person, with a starting capital of €5,000.12 A capital increase in 2024 brought the capital to €50,000.3 In 2025 the registered office moved to Dampremy.4 STEFANELLI Alessio Jean David has served as director since 2022.5 Total assets went from €1.4m in 2023 to €1.6m in 2025.6